Cana­da’s drug price re­forms de­layed to 2021

Amend­ments to Cana­da’s Patent­ed Med­i­cines Reg­u­la­tions will now be put in place 1 Jan­u­ary 2021, de­lay­ing im­ple­men­ta­tion of the sweep­ing drug pric­ing re­forms by six months.

The new time­line rep­re­sents a fur­ther ad­just­ment from the sched­ule laid out in 2017, when Health Cana­da first pro­posed over­haul­ing its drug pric­ing re­view process.

Draft pric­ing guide­lines pro­mul­gat­ed by the gov­ern­ment of Cana­da’s Patent Med­i­cine Prices Re­view Board (PM­PRB) have been avail­able for stake­hold­er and pub­lic con­sul­ta­tion since No­vem­ber 2019. Based on this feed­back, the PM­PRB will re­lease a fi­nal set of re­vised guide­lines the week of 15 June 2020, with a 30-day pe­ri­od of pub­lic writ­ten con­sul­ta­tion to fol­low.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER